LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.15 | 27.76 | 7570 | 5906 | 1.2816 | 1.0652 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.15 | 27.76 | 2052 | 5906 | 0.3474 | 0.7444 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.15 | 27.76 | 7255 | 5906 | 1.2283 | 1.0539 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.85 | 27.76 | 898 | 6062 | 0.1481 | 0.5642 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.85 | 27.76 | 7834 | 6062 | 1.2922 | 1.0671 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.85 | 27.76 | 1986 | 6062 | 0.3276 | 0.7324 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 59.85 | 27.76 | 7507 | 6062 | 1.2382 | 1.0558 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 61.56 | 27.76 | 976 | 6217 | 0.1570 | 0.5777 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 61.56 | 27.76 | 8290 | 6217 | 1.3334 | 1.0751 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 61.56 | 27.76 | 2146 | 6217 | 0.3452 | 0.7453 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 61.56 | 27.76 | 7859 | 6217 | 1.2641 | 1.0609 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.26 | 27.76 | 942 | 6465 | 0.1457 | 0.5655 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.26 | 27.76 | 8665 | 6465 | 1.3402 | 1.0759 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.26 | 27.76 | 2133 | 6465 | 0.3299 | 0.7369 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 63.26 | 27.76 | 8185 | 6465 | 1.2659 | 1.0609 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 64.97 | 27.76 | 917 | 6656 | 0.1378 | 0.5565 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 64.97 | 27.76 | 9032 | 6656 | 1.3568 | 1.0787 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 64.97 | 27.76 | 2302 | 6656 | 0.3458 | 0.7486 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 64.97 | 27.76 | 8459 | 6656 | 1.2707 | 1.0615 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 66.67 | 27.76 | 971 | 6695 | 0.1450 | 0.5670 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 66.67 | 27.76 | 9327 | 6695 | 1.3930 | 1.0855 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 66.67 | 27.76 | 2236 | 6695 | 0.3339 | 0.7412 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 66.67 | 27.76 | 8788 | 6695 | 1.3125 | 1.0699 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 68.37 | 27.76 | 883 | 6879 | 0.1284 | 0.5450 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 68.37 | 27.76 | 9554 | 6879 | 1.3888 | 1.0843 | MN20160318_Q01 | L18 |